Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jun 16, 2021 10:06pm
50 Views
Post# 33400149

RE:RE:RE:7 new jobs posted last evening

RE:RE:RE:7 new jobs posted last eveningStups, market cap is not $100M.

It is currently $135M but the way the sp is dropping, should be to $100M next week.


realstocky wrote:

100M$ for our voucher imo is fair and is equal to present market cap. If thats the way LMNL wants to go, it would make sense so they can finance their business plan, but if it turns out we keep RIPLAZYM, the business plan changes and riplazym become a money maker instantly, both options are a win for different reasons! They are hiring production people so... lets wait for confirmation:) SP at this stage is not that important if the future makes this a 20-30$ stock...lets be patient and ride the swings... ( by the way u can trade for the swings ).

 

 

stockman6767 wrote: " really wish  the deal with kedrion doesnt go through, and lmnl keeps riplazym! 100M$ is nice but mid term, LMNL would make a lot more commercialising riplazym... they are hiring production people, lets see! Personnally im loading up..."

So which is it? Upuntil now, you were touting how great the deal was Kedrion. Now all of a sudden you pivot and tell us it is really better that the option was not picked up by Kedrion, and LMNL is better off keeping Ryplazim and the full PRV for themselves! HUH??


 

 



<< Previous
Bullboard Posts
Next >>